淋巴结阳性食管鳞癌患者从扩大淋巴结清扫术中获益
该研究为随机对照试验的事后亚组分析,纳入129例术后病理证实淋巴结转移的胸段食管鳞癌患者,比较右胸扩大淋巴结清扫与左胸局限淋巴结清扫的5年生存。扩大清扫组5年无病生存率和总生存率均显著优于局限清扫组,且局部区域复发更少。
要点
- 淋巴结阳性食管鳞癌患者,右胸扩大淋巴结清扫较左胸局限清扫改善5年无病生存和总生存。
- 扩大清扫组局部区域复发风险显著降低,远处转移风险有延迟趋势但未达统计学显著。
- 局限清扫、R1/2切缘、TNM IV期及未行术后辅助治疗与总生存降低相关。
核心结论
- 对于术后病理证实淋巴结转移的食管鳞癌患者,经右胸行扩大淋巴结清扫可获得更好的长期生存。
研究设计与样本
- 随机对照试验的事后亚组分析,原试验于2010年5月至2012年7月纳入300例胸段食管癌患者随机接受右胸或左胸路径食管切除术。
- 本分析纳入其中129例术后病理为食管鳞癌且淋巴结转移的患者,扩大清扫组64例,局限清扫组65例,随访5年。
主要发现
- Cox回归显示总生存降低与局限淋巴结清扫、R1/2切除切缘、TNM IV期及缺乏术后辅助治疗相关。
临床怎么用
- 对术前或术后评估存在淋巴结转移的胸段食管鳞癌患者,可优先考虑经右胸行扩大淋巴结清扫以改善长期生存。
局限性
- 本分析为随机对照试验的事后亚组分析,仅纳入129例淋巴结转移患者,样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The usefulness of lymphadenectomy for advanced esophageal cancer is unclear. A post-hoc subgroup analysis involving a randomized controlled trial was performed to compare the long-term survival of patients with esophageal cancer and lymph nodes metastasis (LNM) after extended lymphadenectomy via the right thoracic approach with that of those undergoing limited lymphadenectomy via the left thoracic approach. METHODS: Between May 2010 and July 2012, 300 patients with thoracic esophageal cancer were randomized to undergo esophagectomy through either the right or left thoracic approach. Of these patients, 129 with esophageal squamous cell carcinoma and LNM by postoperative pathology were included in this analysis. Disease-free survival and overall survival (OS) were compared between the extended (n = 64) and limited (n = 65) lymphadenectomy groups after 5 years' follow-up. Cox regression analysis was used to identify the factors associated with OS. RESULTS: The 5-year disease-free survival rates were 40% and 26% in the extended and limited lymphadenectomy groups, respectively (hazard ratio [HR], 1.542; 95% confidence interval [CI], 1.018-2.335; P = .037), and the 5-year OS rates were 51% and 31%, respectively (HR, 1.719; 95% CI, 1.111-2.660; P = .013). The extended lymphadenectomy group had less locoregional recurrence (HR, 0.583; 95% CI, 0.375-0.908; P = .015) and delayed distant metastasis (HR, 1.407; 95% CI, 0.914-2.167; P = .115). Reduced OS was associated with limited lymphadenectomy, R1/2 resection margins, TNM stage IV, and lack of postoperative adjuvant therapy, as per the Cox regression analysis. CONCLUSIONS: Improved long-term survival was observed in patients with esophageal squamous cell carcinoma and LNM after extended lymphadenectomy via the right thoracic approach.
引用
- Li B, Hu H, Zhang Y, et al. Esophageal squamous cell carcinoma patients with positive lymph nodes benefit from extended radical lymphadenectomy. J Thorac Cardiovasc Surg. 2018. PMID: 33198003. doi:10.1016/j.jtcvs.2018.11.094
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。